Endpoints News 生物医药· Nicole DeFeudis·· 2026-10-01AI 评分33
患者死亡引发 Bristol Myers Squibb 肺病候选药物安全性疑虑
Patient death raises liver questions ahead of Bristol Myers readout
AI 导读
Bristol Myers Squibb 公布的肺病候选药物出现一例患者死亡病例,引发安全性问题。该事件发生在公司即将发布相关数据读出之前。
正文
A patient’s death is raising safety questions ahead of an upcoming readout for Bristol Myers Squibb’s lung disease candidate.
Bristol Myers disclosed one case of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news